Dr. Anna Lembke, Professor of Psychiatry, Stanford University School of Medicine
Finding Balance in the Age of Addiction
May 4, 2023; 7pm
In-person event at Sacred Heart Schools, Harman Auditorium, HOMER Bldg
150 Valparaiso Ave, Atherton, CA 94027, USA
"The smartphone is the modern-day hypodermic needle, delivering digital dopamine 24/7 for a wired generation", writes Dr. Anna Lembke in her latest book, Dopamine Nation: Finding Balance in the Age of Indulgence. While our children are digital natives, we’re all vulnerable to compulsive overconsumption with unprecedented access to high-reward, high-dopamine stimuli: drugs, food, news, gambling, shopping, gaming, texting, sexting, Facebooking, Instagramming, YouTubing, tweeting … Dr. Lembke’s talk will explore the benefits of a digital hiatus (and how to do it), and how to moderate compulsive overconsumption in a dopamine-overloaded world.
About Our Speaker
Dr. Lemke is a Professor and Medical Director of Addiction Medicine, at Stanford University School of Medicine. She is also the Program Director of the Stanford Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. A clinician scholar, she has published more than a hundred peer-reviewed papers, book chapters, and commentaries. She sits on the board of several state and national addiction-focused organizations has testified before various committees in the United States House of Representatives and Senate, keeps an active speaking calendar, and maintains a thriving clinical practice.
In 2016, she published Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop which was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic. Dr. Lembke appeared in the Netflix documentary The Social Dilemma, a look at the impact of social media on our lives. Her latest book, Dopamine Nation: Finding Balance in the Age of Indulgence was an instant New York Times and Los Angeles Times bestseller when it debuted in 2021.